Open Beta
MetriLume

US marketsIRMD

SEC-sourced researchBeta

IRMD

IRADIMED CORP

Company comparison ↗

Data passport

CIK
0001325618
Exchange
Nasdaq
Business activity
— · SIC 3841
Financial inputs
6/6
Filing date
Sep 25, 2026
SEC registry record
Operating company

Annual financial history

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.

Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table. Exact amounts and source periods: December 2024: 73,242,000.0000 USD; December 2025: 83,814,000.0000 USD83.8M USD0 USD0December 2024December 2025
IRMD · Exact amounts and source periods · USD
Period endRevenueFiling date
December 202473,242,000.0000Mar 6, 2026
December 202583,814,000.0000Mar 6, 2026

Annual periods · USD

Period endRevenueNet incomeOperating cash flowTotal assetsTotal liabilitiesFiling date
December 202583,814,000.000022,480,000.000024,947,000.0000108,776,000.000014,158,000.0000Mar 6, 2026
December 202473,242,000.000019,234,000.000025,624,000.000098,326,000.000011,507,000.0000Mar 6, 2026

Financial inputs behind the calculation

Financial inputsUSDPeriod endFiling dateForm
RevenueRevenues$83.81MDecember 2025Mar 6, 202610-K
Previous period revenueRevenues$73.24MDecember 2024Mar 6, 202610-K
Net incomeNetIncomeLoss$22.48MDecember 2025Mar 6, 202610-K
Operating cash flowNetCashProvidedByUsedInOperatingActivities$24.95MDecember 2025Mar 6, 202610-K
Total assetsAssets$108.78MDecember 2025Mar 6, 202610-K
Total liabilitiesLiabilities$14.16MDecember 2025Mar 6, 202610-K

New filings

Explore methodology ↗